The Biopsy Devices Market is predicted to reach $ 2214.89 million with a CAGR of 7.4% according to Market Data Forecast report.

The Biopsy Devices Market is predicted to reach $ 2214.89 million with a CAGR of 7.4% according to Market Data Forecast report.

ID: 1696 | December 2016 | Region: Global

The Biopsy Devices Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Biopsy Devices Market is estimated to be $1550 million and predicted to rise to $ 2214.89 million with a CAGR of 7.4%. The market is segmented by Product (Instruments (Manual, Automated and Semi-Automated) and Consumables (Reagents and Kits)), by Type (Needle Biopsy (Core Needle Biopsy, Fine Needle Biopsy and Vacuum-Assisted Biopsy) and Surgical Biopsy (Incisional Biopsy and Excisional Biopsy), by Application (Scientific Research, Medical Diagnosis, Agricultural Applications and Genetic fingerprinting & Sex Determination). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

The market drivers for the biopsy device are the augmented population awareness and increased cancer population, increased demand for screening tests and entry of emerging markets. Low R&D expenses may boost the market share in emerging countries, a great pool of diseases and cancer population points towards the raise in market share of the emerging countries. Lack of technical expertise is hindering the market growth.

Needle based guns are the most lucrative segment. Increasing demand for biopsy guns for acquiring samples from soft tissues such as internal organs like breasts, kidneys, lungs and prostate gland and bone marrow tissue is expected to drive the industry growth during the forecast period.

North America was the largest regional industry, contributing to the largest global share. Europe biopsy devices market share is set to see moderate growth. Asia-Pacific is expected to grow at the fastest CAGR during the forecast period owing to, the presence of high unmet patient needs, coupled with rapidly improving healthcare infrastructure in the emerging countries.

The key companies dominating the biopsy devices market are Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc and Intact Medical Corp.

Browse through the full report at “” and checkout our recent reports in the “Medical Devices” category at “”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)

Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.